Abstract
Barbiturates were suspected of adversely affecting the clinical course of acute porphyria. To assess this objectively, the effect of 9 barbiturates on the porphyrin metabolism of rabbits was observed. These barbiturates may be classified into 4 groups: (a) Diallylbarbituric acid, which caused a considerable rise of urinary coproporphyrin III in each of 8 experimental rabbits and in 3 of these the excretion also of uroporphyrin III and porpho-bilmogen. (b) Allylisopropylbarbituric acid and sodium allyl (1-methylbutyl) barbiturate, which caused a moderate rise of urinary coproporphyrin HI. (c) Sodium diethylbarbiturate, sodium ethyl-(1-methylbutyl) barbiturate and sodium ethylphenyl-barbiturate, which caused only a slight coproporphyrin increase in the urine. (d) Sodium ethyl(l-methylbutyl) thiobarbiturate, sodium isoamylethylbarbiturate and sodium butylethylbarbiturate, which did not alter significantly the urinary coproporphyrin excretion.